Related Experiment Video
Updated: Jul 5, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical
R M Overmeer1, F E Henken, P J F Snijders
1Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Abstract:
We previously showed that silencing of TSLC1, recently renamed CADM1, is functionally involved in high-risk HPV-mediated cervical carcinogenesis. CADM1 silencing often results from promoter methylation. Here, we determined the extent of CADM1 promoter methylation in cervical (pre)malignant lesions and its relation to anchorage-independent growth and gene silencing to select a CADM1-based methylation marker for identification of women at risk of cervical cancer. Methylation-specific PCRs targeting three regions within the CADM1 promoter were performed on high-risk HPV-containing cell lines, PBMCs, normal cervical smears, and (pre)malignant lesions. CADM1 protein expression in cervical tissues was analysed by immunohistochemistry. All statistical tests were two-sided. Density of methylation was associated with the degree of anchorage-independent growth and CADM1 gene silencing in vitro. In cervical squamous lesions, methylation frequency and density increased with severity of disease. Dense methylation (defined as >or= 2 methylated regions) increased from 5% in normal cervical samples to 30% in CIN3 lesions and 83% in squamous cell carcinomas (SCCs) and was significantly associated with decreased CADM1 protein expression (p < 0.00005). The frequency of dense methylation was significantly higher in >or= CIN3 compared with
Insights
Cell adhesion molecule 1 (CADM1) promoter methylation increases with cervical lesion severity. Dense methylation is a promising biomarker for identifying women at high risk of cervical cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gynecology
Background:
- TSLC1, now known as CADM1, is implicated in high-risk HPV-mediated cervical carcinogenesis.
- CADM1 silencing is frequently caused by promoter methylation.
Purpose of the Study:
- To assess CADM1 promoter methylation in cervical lesions.
- To correlate methylation with anchorage-independent growth and gene silencing.
- To identify a CADM1-based methylation marker for cervical cancer risk stratification.
Main Methods:
- Methylation-specific PCR on cell lines, PBMCs, and cervical samples (normal to malignant).
- Immunohistochemistry to analyze CADM1 protein expression in cervical tissues.
- Statistical analysis of methylation density, disease severity, and protein expression.
Main Results:
- Methylation density correlated with anchorage-independent growth and CADM1 gene silencing.
- Methylation frequency and density increased with cervical lesion severity.
- Dense methylation (>or= 2 regions) rose from 5% in normal samples to 83% in squamous cell carcinomas (SCCs), significantly decreasing CADM1 expression.
- Dense methylation was significantly higher in CIN3+ lesions and SCCs compared to adenocarcinomas.
Conclusions:
- Dense CADM1 promoter methylation is significantly associated with cervical carcinogenesis.
- CADM1 promoter methylation serves as a potential biomarker for identifying high-risk HPV-positive women.
- This marker can aid in assembling a panel for triaging women at risk of CIN3+.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...